Latest News about ABT
Recent news which mentions ABT
Want Passive Income in 2023? Buy These Dividend Kings
November 22, 2022
From Motley Fool
2 Stocks Down 75% and 26% to Buy Right Now
November 17, 2022
From Motley Fool
FDA Outlines Strategy To Review Infant Formula Production Rules
November 16, 2022
Tickers
ABT
From Benzinga
7 No-Brainer Blue-Chip Stocks to Buy for 2023 and Beyond
November 12, 2022
From InvestorPlace
Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today
November 10, 2022
Tickers
ABT
From Benzinga
Better Buy: Johnson & Johnson vs. Abbott Laboratories
November 10, 2022
From Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
November 10, 2022
From Motley Fool
3 Food Processing Dividend Stocks That Could Benefit From Food Shortages Driven By Russia-Ukraine War
November 09, 2022
From Benzinga
Got $1,000? 2 Bear Market Stocks to Jump On Right Now
November 08, 2022
From Motley Fool
Investing $1,000 in the Current Market? Don't Overlook These 2 Winning Dividend Stocks
November 08, 2022
From Motley Fool
2 Reasons to Buy DexCom, and 1 Reason to Sell
November 07, 2022
From Motley Fool
3 Reasons to Buy AbbVie Stock Right Now
November 05, 2022
From Motley Fool
From Benzinga
Got $5,000? Buy These 3 Dividend Kings And Hold Them Forever
November 02, 2022
From Motley Fool
Is DexCom a Good Healthcare Stock to Buy Now?
November 02, 2022
From Motley Fool
3 Dividend-Paying Stocks to Buy in November and Hold Forever
November 02, 2022
From Motley Fool
This Groundbreaking Device Just Keeps Winning for Abbott Labs
November 01, 2022
Tickers
ABT
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
October 26, 2022
From Benzinga
Is Abbott Laboratories Still a Good Dividend Stock to Buy?
October 22, 2022
Tickers
ABT
From Motley Fool
Amazon To $175? Plus JP Morgan Cuts Price Target On Meta Platforms
October 21, 2022
From Benzinga
Want Passive Income? 3 Dividend Kings to Buy Right Now
October 21, 2022
From Motley Fool
Patients are getting surgeries again, says J&J
October 20, 2022
From MarketWatch
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
From Benzinga
From Motley Fool
From Benzinga
3 Stocks Set to Soar From 52-Week Lows
October 19, 2022
From InvestorPlace
Abbott Laboratories predicts COVID-19 will be endemic this winter
October 19, 2022
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.